Digital Transformation Leads to New Growth Strategies for Stakeholders
The global COVID-19 pandemic and other geo-political events left many businesses facing an unprecedented state of uncertainty. Healthcare companies across the care continuum remain grappling with these new challenges, of which the extent and longevity remain unknown. Spurred by the year’s events, healthcare delivery has accelerated its transformation, and the concept of anytime-anywhere care has taken course to become mainstream. Digital health applications-especially telehealth and remote patient monitoring-saw tremendous demand as the only means to continue care delivery for many during the pandemic.
To align with the new normal, vendors will need to redefine their visions and strategies, ensuring they are ready to tackle 2021 and beyond. Use of artificial intelligence (AI) across the spectrum of applications, cloud computing, patient engagement solutions, and home monitoring represent strong opportunities for growth. The new vision for healthcare in 2021 will focus on access, quality, and affordability, in addition to strategies designed to overcome the losses sustained in 2020, while ensuring healthcare remains precise, preventive, and outcome-based in the promotion of social and financial inclusion.
Research Highlights
This study covers aspects of the global healthcare industry that develop and provide products, solutions, and/or services across the care spectrum for diagnosis, treatment, and prevention. Key sectors considered in the study scope are pharmaceuticals and biotechnology (pharma & biotech); in-vitro diagnostics (IVD); advanced medical technologies; medical imaging and informatics; and digital health. The study period is 2019 to 2025 using a base year of 2020.
The 2021 Outlook concludes with a discussion of five growth opportunities identified by the publisher as the major areas where competitors in this space must take action.